Routine: IBDEI2KO

IBDEI2KO ; ; 04-FEB-2020

 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020

 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y

Q Q

 ;;^UTILITY(U,$J,358.3,41055,1,3,0)

 ;;=3^Progressive Supranuclear Ophthalmoplegia

 ;;^UTILITY(U,$J,358.3,41055,1,4,0)

 ;;=4^G23.1

 ;;^UTILITY(U,$J,358.3,41055,2)

 ;;=^5003780

 ;;^UTILITY(U,$J,358.3,41056,0)

 ;;=Z79.2^^152^2021^1

 ;;^UTILITY(U,$J,358.3,41056,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,41056,1,3,0)

 ;;=3^Antibiotics

 ;;^UTILITY(U,$J,358.3,41056,1,4,0)

 ;;=4^Z79.2

 ;;^UTILITY(U,$J,358.3,41056,2)

 ;;=^321546

 ;;^UTILITY(U,$J,358.3,41057,0)

 ;;=Z79.01^^152^2021^2

 ;;^UTILITY(U,$J,358.3,41057,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,41057,1,3,0)

 ;;=3^Anticoagulants

 ;;^UTILITY(U,$J,358.3,41057,1,4,0)

 ;;=4^Z79.01

 ;;^UTILITY(U,$J,358.3,41057,2)

 ;;=^5063330

 ;;^UTILITY(U,$J,358.3,41058,0)

 ;;=Z79.02^^152^2021^3

 ;;^UTILITY(U,$J,358.3,41058,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,41058,1,3,0)

 ;;=3^Antiplatelets/Antithrombotics

 ;;^UTILITY(U,$J,358.3,41058,1,4,0)

 ;;=4^Z79.02

 ;;^UTILITY(U,$J,358.3,41058,2)

 ;;=^5063331

 ;;^UTILITY(U,$J,358.3,41059,0)

 ;;=Z79.82^^152^2021^4

 ;;^UTILITY(U,$J,358.3,41059,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,41059,1,3,0)

 ;;=3^Aspirin

 ;;^UTILITY(U,$J,358.3,41059,1,4,0)

 ;;=4^Z79.82

 ;;^UTILITY(U,$J,358.3,41059,2)

 ;;=^5063340

 ;;^UTILITY(U,$J,358.3,41060,0)

 ;;=Z79.4^^152^2021^6

 ;;^UTILITY(U,$J,358.3,41060,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,41060,1,3,0)

 ;;=3^Insulin

 ;;^UTILITY(U,$J,358.3,41060,1,4,0)

 ;;=4^Z79.4

 ;;^UTILITY(U,$J,358.3,41060,2)

 ;;=^5063334

 ;;^UTILITY(U,$J,358.3,41061,0)

 ;;=Z79.1^^152^2021^9

 ;;^UTILITY(U,$J,358.3,41061,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,41061,1,3,0)

 ;;=3^NSAID

 ;;^UTILITY(U,$J,358.3,41061,1,4,0)

 ;;=4^Z79.1

 ;;^UTILITY(U,$J,358.3,41061,2)

 ;;=^5063332

 ;;^UTILITY(U,$J,358.3,41062,0)

 ;;=Z79.891^^152^2021^8

 ;;^UTILITY(U,$J,358.3,41062,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,41062,1,3,0)

 ;;=3^Long Term Opiate/Opioid Analgesic Use

 ;;^UTILITY(U,$J,358.3,41062,1,4,0)

 ;;=4^Z79.891

 ;;^UTILITY(U,$J,358.3,41062,2)

 ;;=^5063342

 ;;^UTILITY(U,$J,358.3,41063,0)

 ;;=Z79.51^^152^2021^5

 ;;^UTILITY(U,$J,358.3,41063,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,41063,1,3,0)

 ;;=3^Inhaled Steroids

 ;;^UTILITY(U,$J,358.3,41063,1,4,0)

 ;;=4^Z79.51

 ;;^UTILITY(U,$J,358.3,41063,2)

 ;;=^5063335

 ;;^UTILITY(U,$J,358.3,41064,0)

 ;;=Z79.52^^152^2021^11

 ;;^UTILITY(U,$J,358.3,41064,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,41064,1,3,0)

 ;;=3^Steroids-Systemic

 ;;^UTILITY(U,$J,358.3,41064,1,4,0)

 ;;=4^Z79.52

 ;;^UTILITY(U,$J,358.3,41064,2)

 ;;=^5063336

 ;;^UTILITY(U,$J,358.3,41065,0)

 ;;=Z79.899^^152^2021^7

 ;;^UTILITY(U,$J,358.3,41065,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,41065,1,3,0)

 ;;=3^Long Term Current Drug Therapy NEC

 ;;^UTILITY(U,$J,358.3,41065,1,4,0)

 ;;=4^Z79.899

 ;;^UTILITY(U,$J,358.3,41065,2)

 ;;=^5063343

 ;;^UTILITY(U,$J,358.3,41066,0)

 ;;=Z79.84^^152^2021^10

 ;;^UTILITY(U,$J,358.3,41066,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,41066,1,3,0)

 ;;=3^Oral Hypoglycemic Drugs

 ;;^UTILITY(U,$J,358.3,41066,1,4,0)

 ;;=4^Z79.84

 ;;^UTILITY(U,$J,358.3,41066,2)

 ;;=^5140432

 ;;^UTILITY(U,$J,358.3,41067,0)

 ;;=Z90.13^^152^2022^5

 ;;^UTILITY(U,$J,358.3,41067,1,0)

 ;;=^358.31IA^4^2

 ;;^UTILITY(U,$J,358.3,41067,1,3,0)

 ;;=3^Acquired Absence of Breasts & Nipples,Bilateral

 ;;^UTILITY(U,$J,358.3,41067,1,4,0)

 ;;=4^Z90.13

 ;;^UTILITY(U,$J,358.3,41067,2)

 ;;=^5063584

 ;;^UTILITY(U,$J,358.3,41068,0)

 ;;=Z90.710^^152^2022^6

--- Routine Detail   --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2KO   3790     printed  Feb 18, 2025@23:57:03                                                                                                                                                                                                    Page 2

IBDEI2KO  ; ; 04-FEB-2020

 +1       ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020

 +2        if 'DIFQR(358.3)

               QUIT

           FOR I=1:2

               SET X=$TEXT(Q+I)

               if X=""

                   QUIT

               SET Y=$EXTRACT($TEXT(Q+I+1),4,999)

               SET X=$EXTRACT(X,4,999)

               if $ASCII(Y)=126

                   SET I=I+1

                   SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)

               if $ASCII(Y)=61

                   SET Y=$EXTRACT(Y,2,999)

               XECUTE NO

              IF '$TEST

                   SET @X=Y

Q          QUIT

 +1       ;;^UTILITY(U,$J,358.3,41055,1,3,0)

 +2       ;;=3^Progressive Supranuclear Ophthalmoplegia

 +3       ;;^UTILITY(U,$J,358.3,41055,1,4,0)

 +4       ;;=4^G23.1

 +5       ;;^UTILITY(U,$J,358.3,41055,2)

 +6       ;;=^5003780

 +7       ;;^UTILITY(U,$J,358.3,41056,0)

 +8       ;;=Z79.2^^152^2021^1

 +9       ;;^UTILITY(U,$J,358.3,41056,1,0)

 +10      ;;=^358.31IA^4^2

 +11      ;;^UTILITY(U,$J,358.3,41056,1,3,0)

 +12      ;;=3^Antibiotics

 +13      ;;^UTILITY(U,$J,358.3,41056,1,4,0)

 +14      ;;=4^Z79.2

 +15      ;;^UTILITY(U,$J,358.3,41056,2)

 +16      ;;=^321546

 +17      ;;^UTILITY(U,$J,358.3,41057,0)

 +18      ;;=Z79.01^^152^2021^2

 +19      ;;^UTILITY(U,$J,358.3,41057,1,0)

 +20      ;;=^358.31IA^4^2

 +21      ;;^UTILITY(U,$J,358.3,41057,1,3,0)

 +22      ;;=3^Anticoagulants

 +23      ;;^UTILITY(U,$J,358.3,41057,1,4,0)

 +24      ;;=4^Z79.01

 +25      ;;^UTILITY(U,$J,358.3,41057,2)

 +26      ;;=^5063330

 +27      ;;^UTILITY(U,$J,358.3,41058,0)

 +28      ;;=Z79.02^^152^2021^3

 +29      ;;^UTILITY(U,$J,358.3,41058,1,0)

 +30      ;;=^358.31IA^4^2

 +31      ;;^UTILITY(U,$J,358.3,41058,1,3,0)

 +32      ;;=3^Antiplatelets/Antithrombotics

 +33      ;;^UTILITY(U,$J,358.3,41058,1,4,0)

 +34      ;;=4^Z79.02

 +35      ;;^UTILITY(U,$J,358.3,41058,2)

 +36      ;;=^5063331

 +37      ;;^UTILITY(U,$J,358.3,41059,0)

 +38      ;;=Z79.82^^152^2021^4

 +39      ;;^UTILITY(U,$J,358.3,41059,1,0)

 +40      ;;=^358.31IA^4^2

 +41      ;;^UTILITY(U,$J,358.3,41059,1,3,0)

 +42      ;;=3^Aspirin

 +43      ;;^UTILITY(U,$J,358.3,41059,1,4,0)

 +44      ;;=4^Z79.82

 +45      ;;^UTILITY(U,$J,358.3,41059,2)

 +46      ;;=^5063340

 +47      ;;^UTILITY(U,$J,358.3,41060,0)

 +48      ;;=Z79.4^^152^2021^6

 +49      ;;^UTILITY(U,$J,358.3,41060,1,0)

 +50      ;;=^358.31IA^4^2

 +51      ;;^UTILITY(U,$J,358.3,41060,1,3,0)

 +52      ;;=3^Insulin

 +53      ;;^UTILITY(U,$J,358.3,41060,1,4,0)

 +54      ;;=4^Z79.4

 +55      ;;^UTILITY(U,$J,358.3,41060,2)

 +56      ;;=^5063334

 +57      ;;^UTILITY(U,$J,358.3,41061,0)

 +58      ;;=Z79.1^^152^2021^9

 +59      ;;^UTILITY(U,$J,358.3,41061,1,0)

 +60      ;;=^358.31IA^4^2

 +61      ;;^UTILITY(U,$J,358.3,41061,1,3,0)

 +62      ;;=3^NSAID

 +63      ;;^UTILITY(U,$J,358.3,41061,1,4,0)

 +64      ;;=4^Z79.1

 +65      ;;^UTILITY(U,$J,358.3,41061,2)

 +66      ;;=^5063332

 +67      ;;^UTILITY(U,$J,358.3,41062,0)

 +68      ;;=Z79.891^^152^2021^8

 +69      ;;^UTILITY(U,$J,358.3,41062,1,0)

 +70      ;;=^358.31IA^4^2

 +71      ;;^UTILITY(U,$J,358.3,41062,1,3,0)

 +72      ;;=3^Long Term Opiate/Opioid Analgesic Use

 +73      ;;^UTILITY(U,$J,358.3,41062,1,4,0)

 +74      ;;=4^Z79.891

 +75      ;;^UTILITY(U,$J,358.3,41062,2)

 +76      ;;=^5063342

 +77      ;;^UTILITY(U,$J,358.3,41063,0)

 +78      ;;=Z79.51^^152^2021^5

 +79      ;;^UTILITY(U,$J,358.3,41063,1,0)

 +80      ;;=^358.31IA^4^2

 +81      ;;^UTILITY(U,$J,358.3,41063,1,3,0)

 +82      ;;=3^Inhaled Steroids

 +83      ;;^UTILITY(U,$J,358.3,41063,1,4,0)

 +84      ;;=4^Z79.51

 +85      ;;^UTILITY(U,$J,358.3,41063,2)

 +86      ;;=^5063335

 +87      ;;^UTILITY(U,$J,358.3,41064,0)

 +88      ;;=Z79.52^^152^2021^11

 +89      ;;^UTILITY(U,$J,358.3,41064,1,0)

 +90      ;;=^358.31IA^4^2

 +91      ;;^UTILITY(U,$J,358.3,41064,1,3,0)

 +92      ;;=3^Steroids-Systemic

 +93      ;;^UTILITY(U,$J,358.3,41064,1,4,0)

 +94      ;;=4^Z79.52

 +95      ;;^UTILITY(U,$J,358.3,41064,2)

 +96      ;;=^5063336

 +97      ;;^UTILITY(U,$J,358.3,41065,0)

 +98      ;;=Z79.899^^152^2021^7

 +99      ;;^UTILITY(U,$J,358.3,41065,1,0)

 +100     ;;=^358.31IA^4^2

 +101     ;;^UTILITY(U,$J,358.3,41065,1,3,0)

 +102     ;;=3^Long Term Current Drug Therapy NEC

 +103     ;;^UTILITY(U,$J,358.3,41065,1,4,0)

 +104     ;;=4^Z79.899

 +105     ;;^UTILITY(U,$J,358.3,41065,2)

 +106     ;;=^5063343

 +107     ;;^UTILITY(U,$J,358.3,41066,0)

 +108     ;;=Z79.84^^152^2021^10

 +109     ;;^UTILITY(U,$J,358.3,41066,1,0)

 +110     ;;=^358.31IA^4^2

 +111     ;;^UTILITY(U,$J,358.3,41066,1,3,0)

 +112     ;;=3^Oral Hypoglycemic Drugs

 +113     ;;^UTILITY(U,$J,358.3,41066,1,4,0)

 +114     ;;=4^Z79.84

 +115     ;;^UTILITY(U,$J,358.3,41066,2)

 +116     ;;=^5140432

 +117     ;;^UTILITY(U,$J,358.3,41067,0)

 +118     ;;=Z90.13^^152^2022^5

 +119     ;;^UTILITY(U,$J,358.3,41067,1,0)

 +120     ;;=^358.31IA^4^2

 +121     ;;^UTILITY(U,$J,358.3,41067,1,3,0)

 +122     ;;=3^Acquired Absence of Breasts & Nipples,Bilateral

 +123     ;;^UTILITY(U,$J,358.3,41067,1,4,0)

 +124     ;;=4^Z90.13

 +125     ;;^UTILITY(U,$J,358.3,41067,2)

 +126     ;;=^5063584

 +127     ;;^UTILITY(U,$J,358.3,41068,0)

 +128     ;;=Z90.710^^152^2022^6

IBDEI2KO.m